Press releases | WebDisclosure

Basculer en Français

9567	Companies
189183	Keywords
120875	Articles
100942	Press releases

Home
Press releases

PRESS RELEASE

published on 06/30/2025 at 22:30, 5 months 22 days ago

EUROPLASMA: Démenti à la suite de fausses informations publiées par le site Boursier.com
Europlasma dément formellement les fausses informations diffusées par Boursier.com concernant un prétendu nouveau financement obligataire. Le groupe annonce son intention de déposer plainte pour diffusion de fausses informations et manipulation de cours

Europlasma Décarbonation Démenti Plainte Fausses Informations
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 5 months 22 days ago

Information sur les comptes annuels
Biophytis SA informe qu'elle n'est pas en mesure de publier ses comptes annuels 2024 à la date prévue mais les publiera au plus tard le 07 juillet 2025

Biophytis Développement Biotechnologie Comptes Annuels Maladies Liées À L'âge
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 5 months 22 days ago

Information on the Annual Financial Statements
Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases

Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company
PRESS RELEASE

published on 06/30/2025 at 22:30, 5 months 22 days ago

LE GROUPE LUCIBEL ANNONCE SES RÉSULTATS ANNUELS 2024
Le Groupe Lucibel annonce ses résultats 2024 et son plan de restructuration visant la rentabilité. Analyse des chiffres, perspectives 2025 et situation financière détaillée

Restructuration Résultats 2024 Situation Financière Groupe Lucibel Perspectives 2025
PRESS RELEASE

published on 06/30/2025 at 22:29, 5 months 22 days ago

Information sur les comptes annuels
Biophytis SA informe qu'elle reporte la publication de ses comptes annuels 2024 mais s'engage pour une publication rapide. Analyse des risques liés aux déclarations prospectives incluses

Comptes Annuels Déclarations Prospectives Publication Biophytis SA Risques
PRESS RELEASE

published on 06/30/2025 at 22:29, 5 months 22 days ago

Information on the Annual Financial Statements
Biophytis SA delays publication of 2024 annual accounts, aiming to release by July 7. The clinical-stage biotech company focuses on age-related disease treatments

Biotechnology Company Clinical-stage Biophytis SA Age-related Diseases 2024 Annual Accounts
PRESS RELEASE

published on 06/30/2025 at 22:05, 5 months 22 days ago

Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity
Protagonist Therapeutics announces development candidate PN-477, a triple agonist peptide, targeting GLP-1, GIP, GCG receptors for obesity treatment. IND-enabling studies in progress, Phase I initiation expected in 2Q26

GLP-1 Protagonist Therapeutics PN-477 GIP GCG Receptors
PRESS RELEASE

published on 06/30/2025 at 22:00, 5 months 22 days ago

aap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment
aap Implantate AG successfully closes financial year 2024 with positive developments, achieving sales growth and strengthening market position, especially in EMEA and LATAM regions

Sales Growth Financial Year 2024 Aap Implantate AG EMEA Region LATAM Region
PRESS RELEASE

published on 06/30/2025 at 21:33, 5 months 22 days ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 06/30/2025 at 21:33, 5 months 22 days ago

Sanofi : Déclaration des transactions sur actions propres

Accesswire

Published on 12/23/2025 at 03:00, 4 hours 15 minutes ago

Forte Group Receives BC Liquor Co-Packing Licence, Expanding Beverage Alcohol and Zero-Proof Manufacturing Capabilities at Its British Columbia Beverage Manufacturing Facility
Published on 12/22/2025 at 23:35, 7 hours 40 minutes ago

Cypher Metaverse Inc. Announces Closing of Financing
Published on 12/22/2025 at 23:05, 8 hours 10 minutes ago

BlackBerry to Host Investor Briefing at CES 2026
Published on 12/22/2025 at 22:50, 8 hours 25 minutes ago

American Critical Minerals Clarifies Technical Disclosure
Published on 12/22/2025 at 22:35, 8 hours 40 minutes ago

NioCorp to Begin Construction of Mine Portal at Its Elk Creek Critical Minerals Project

View all ACCESSWIRE

EQS Group

Published on 12/23/2025 at 07:00, 15 minutes ago

Xlife Sciences AG Announces Transition to the Main Segment of SIX Swiss Exchange to Strengthen Market Presence
Published on 12/23/2025 at 07:00, 15 minutes ago

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
Published on 12/23/2025 at 00:15, 7 hours ago

FINALS, SEMI-FINALS AND NON-STOP ACTION AS GOTF 2025 REACHES CLIMAX
Published on 12/22/2025 at 22:05, 9 hours 10 minutes ago

mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
Published on 12/22/2025 at 21:36, 9 hours 39 minutes ago

Revolution Wind and Sunrise Wind receive lease suspension orders from US Department of the Interior’s Bureau of Ocean Energy Management

Les Echos

Published on 12/22/2025 at 18:33, 12 hours 42 minutes ago

ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 13 hours 10 minutes ago

Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 13 hours 10 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 13 hours 30 minutes ago

Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 13 hours 40 minutes ago

DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025

View all LES ECHOS COMFI WIRE